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this domain.
Methods.– We reviewed patients who received BTI (2006–2011) for post-
traumatic contractures of the upper limb. They were assessed for passive and
active range of movement, pain (visual analogic scale) and passive and active
functions.
Case reports.– The first patient suffered from severe and painful post-traumatic
contractures of elbow and wrist flexors, following elbow dislocation, which
severely limited joint extension and use of the hand. Oral treatment and
physiotherapy had a very limited effect. Repeated BTI were performed in
contractured and painful muscles, with limited doses (100U Botox#), each 2–3
months. In the 4–5 days following each injection, contracture and pain were
reduced and this favoured active function of the antagonist muscles. Recovery was
complete after four injection sessions, with fair satisfaction level. The second
patient had been the victim of a traumatic injury of the upper extremity, with
compartment syndrome. She suffered from severe multifocal painful contractures,
impairing daily living, with loss of usage of the limb. Oral treatments and physical
therapy had a modest effect. Iterative BTI were performed every four months
(200U Botox#) for four years, with a partial, recurrent and constant gain on pain,
active motricity, use of the limb, and level of satisfaction
Conclusion.– Following arthroplasty, BTI has yet shown definite effect on
painful contractures of the hip and knee. Here, we present the first reports of
such a symptomatic and functional effect on severe post-traumatic contractures.
Botulinum toxin injections must be considered as a useful treatment for post-
traumatic disabling contractures.
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Introduction.– Etiologies of exertional leg pain are numerous and may be
associated. This diversity requires a precise diagnostic break-up, and makes its
therapeutic management sometimes complex. How should some abnormalities
(supernumerary muscles, functional popliteal arteries entrapment) be handled
when their imputability in pain is uncertain? Botulinum toxin type A (BTX-A)
has been successfully used for several years in some lesions of the locomotor
apparatus. Our objective is to demonstrate its diagnostic and therapeutic interest
in the chronic compartment syndrome (CCS), functional popliteal artery
entrapment syndrome and the accessory soleus muscle.Observation.– We are
presenting a few studies or case series which are in the process of being analysed
or published. The first open and prospective study demonstrates the diagnostic
and therapeutic interest of BTX-A in 31 patients with antero-external CCS of
the leg of a mean duration of 31 months. Pain disappeared in 97% of cases. A
moderate muscular deficiency is nearly constant and disappears between 1 and 5
months in 94% of cases, preventing only exceptionally an early resumption of
running. Intramuscular pressures, three months after BTX-A, had normalized.
Eight patients presented a recurrence of pain between 6 and 30 months.
In three patients with painful accessory soleus muscle treated by BTX-A
injection within the muscle by stimulodetection, pain had disappeared. Two
patients relapsed at distance.
Five patients presenting with a functional trapped popliteal artery without
anatomical lesion were treated by BTX-A injection. The results are in the
process of analysis. A first patient was able to resume sport, as pain had
disappeared and the echographic dynamic abnormalities had normalized.Dis-
cussion.– The precise use of BTX-A is a useful adjuvant in the diagnostic break-
up of exertional leg pain, in addition to the absolutely essential complementary
tests. It allows precising the imputability of anatomical or functional
abnormalities in the origin of pain. BTX-A has its own therapeutic actionallowing a prolonged amendment of some types of pain. In case of recurrence, it
is an excellent pre-surgical test in non-responding pain with uncertain surgical
results.
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Introduction.– CRPS remains a phenomenon not clearly understood
physiologically. Three phases follow one another: hot, cold and retractile. A
symptomatic element of dystonia may appear from the cold phase,
characterized by tonic muscle contractions and abnormal postures.
Observation.– A 42 year old woman presents with a epitrochlea fracture of the
left humerus further complicated by ulnar nerve compression which was treated
by arthroscopic surgery. Two years later, with no obvious trigger, the patient
develops pain and swelling of the left arm, and a progressive stiffness of the
hand of attributed to (CRPS). Clinical examination of passive range of motion
revealed the following limitations: shoulder abduction of 308, flexion at 408,
elbow pronation of 608, supination to –458, writs extension of –608, radial
rotation at –208 and pulpo-palmar distance of II to V fingers at 0 mm. The
patient was treated with marcaine for regional local nerve blocks followed by
intensive rehabilitation, without results. Three years later, the patient was
referred to us for further treatment of her dystonia. We used botulinum toxin to
inject the trapezius, teres major, pectoralis major, pronator teres, flexor carpi
radialis, superficial and deep common flexors of the second to fifth fingers. We
used alcohol nerve blocks administered to the palmar muscles, common flexors,
and flexor pollicis longus 15 days later resulting in a clear measurable functional
improvements with shoulder abduction of 808, shoulder flexion of 1508, elbow
pronation 908 and supination to 808, wrist extension at 308, radial rotation of 08,
and the pulpo-palmar distances of 80 mm, 50 mm, 60 mm, 70 mm for second,
third, fourth, and fifth fingers, respectively.
Discussion.– The literature on CRPS dystonia is very scarce, the use of
botulinum toxin as well as intensive active and passive rehabilitation in
conjunction with psychotherapy can be an effective therapeutic combination.
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Introduction.– Botulinum toxin (BT) can be used in the treatment of neck and
upper limb pain and in the management of low back pain with or without
sciatica. Its use and justification in these indications are based on the myofascial
pain concept according to Travell, which would be a malfunction of the motor
endplate with excessive release of acetylcholine.
